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Abstract
Background: Tobacco use remains prevalent among Veterans of military service and those residing in rural areas.
Smokers frequently experience tobacco-related issues including risky alcohol use, post-cessation weight gain, and
depressive symptoms that may adversely impact their likelihood of quitting and maintaining abstinence.
Telephone-based interventions that simultaneously address these issues may help to increase treatment access and
improve outcomes.
Methods: This study was a two-group randomized controlled pilot trial. Participants were randomly assigned to an
individually-tailored telephone tobacco intervention combining counseling for tobacco use and related issues
including depressive symptoms, risky alcohol use, and weight concerns or to treatment provided through their
state tobacco quitline. Selection of pharmacotherapy was based on medical history and a shared decision interview
in both groups. Participants included 63 rural Veteran smokers (mean age = 56.8 years; 87 % male; mean number of
cigarettes/day = 24.7). The primary outcome was self-reported 7-day point prevalence abstinence at 12 weeks and
6 months.
Results: Twelve-week quit rates based on an intention-to-treat analysis did not differ significantly by group
(Tailored = 39 %; Quitline Referral = 25 %; odds ratio [OR]; 95 % confidence interval [CI] = 1.90; 0.56, 5.57). Six-month
quit rates for the Tailored and Quitline Referral conditions were 29 and 28 %, respectively (OR; 95 % CI = 1.05; 0.35, 3.12).
Satisfaction with the Tailored tobacco intervention was high.
Conclusions: Telephone-based treatment that concomitantly addresses other health-related factors that may adversely
affect quitting appears to be a promising strategy. Larger studies are needed to determine whether this approach
improves cessation outcomes.
Trial registration: ClinicalTrials.gov identifier number NCT01592695 registered 11 April 2012.
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Background
Although the prevalence of cigarette smoking among
adults in the United States (US) continues to decline,
rates remain elevated in certain groups including mili-
tary Veterans [1] and those living in rural areas [2]. The
reasons for greater tobacco use in rural communities are
complex and likely include a combination of personal
characteristics (e.g., higher prevalence of low socioeco-
nomic status) and social or community-related factors
such as targeted marketing by the tobacco industry, eco-
nomic dependence on tobacco growing in certain farm-
ing communities, greater social acceptance of smoking,
and lax policies restricting smoking in private and public
locations [2–4]. Health care-associated factors including
limited access to treatment also appear to contribute
[3, 4]. Being uninsured [4, 5], infrequent visits to and/
or lack of a personal physician [4, 5], a lower likelihood of
being counseled about tobacco use [6], and insufficient
knowledge about available treatment resources also likely
play a role [4, 7]. Considering that approximately 5.3 mil-
lion Veterans, representing 24 % of all Veterans living in
the US, reside in rural areas [8], this represents a substan-
tial group of individuals who are at increased risk for
smoking-related health problems.
Tobacco quitlines are often advocated as a strategy to
improve treatment access. Proactive telephone counsel-
ing is efficacious [9] and cost-effective [10]. Unfortu-
nately, these services are underutilized, with only 1–5 %
of eligible smokers receiving this form of treatment [11].
Many referred patients cannot be reached or are reluc-
tant to enroll in quitline counseling [12], suggesting that
additional efforts are needed to connect smokers with
treatment resources.
There are also several health-related factors that may
adversely affect cessation outcomes once patients are en-
rolled in treatment including depressive symptoms [13],
risky alcohol use [14], and concerns about weight gain
[13–17]. However, standard cessation interventions are
typically not designed to treat these concerns, leading
for calls to develop strategies that more effectively ad-
dress these issues [13–17].
Traditionally, depression, alcohol use, and weight
management have been addressed independently of to-
bacco use, often using behavioral health and nutrition
specialists. Unfortunately, requiring separate treatment
by specialists for each of these conditions may exacer-
bate problems related to access for rural smokers. Fur-
ther, such efforts tend to be poorly coordinated,
resulting in fragmented care that does not take advan-
tage of the synergies and increased efficiencies provided
by addressing these issues in an integrated fashion [18].
Coordinated treatment models led by a care manager
and in which mental health care experts serve as consul-
tants to primary care have been shown to improve
outcomes in patients with depression [19, 20]. However,
such approaches have not been adequately evaluated in
the context of treatment for tobacco use. Further, evi-
dence suggests that this model may not be as effective in
small rural primary care practice settings which do not
have on-site mental health care providers [21].
Taken together, these findings suggest that comorbid
issues related to depressive symptoms, risky alcohol use,
and weight concerns are common among smokers and
may interfere with quitting, but are not typically addressed
in treatment. The goals of this pilot trial were to determine
the feasibility and potential efficacy of an individually-
tailored cessation intervention for rural Veteran smokers
that simultaneously addressed these issues.
Methods
The study was a randomized controlled pilot trial of two
treatment approaches (tailored telephone counseling to
address cigarette smoking and concomitant depressive
symptoms, risky alcohol use, and/or weight concerns
[Tailored] vs. referral to the participants’ state tobacco
quitline [Quitline Referral]). The primary outcome was
7-day point prevalence abstinence at 12 weeks and
6 months after participants’ target quit dates.
Participants
Participants included rural Veteran daily cigarette
smokers aged ≥ 18 years who were interested in quitting
and received care at a Midwestern VA Medical Center.
Individuals were excluded if they did not have telephone
access, were unable to provide informed consent, or did
not have a stable residence. Those with a history of de-
mentia or other significant cognitive impairment or a
serious mental illness that would interfere with their
ability to participate in phone counseling (e.g., catatonic
or disorganized schizophrenia) were also excluded based
on diagnoses contained in the electronic medical record
(EMR). We also excluded patients with markedly ele-
vated depressive symptoms and/or suicidal ideation (see
below).
Procedures
Potentially eligible participants were identified from
the EMR based on (a) documented cigarette use or
(b) recent (within 2 years) prescription for nicotine
replacement therapy (NRT), bupropion, or varenicline
and (c) an address indicating rural residence, determined
using Rural–urban Commuting Area codes based on zip
code [22]. Patients meeting basic eligibility criteria were
sent a letter offering them participation in the trial, to
which they could respond by returning a self-addressed
postcard or contacting study staff by phone. Those
expressing interest were mailed an informed consent
document and baseline questionnaire, which included
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screening items to assess for eligibility for the supple-
mental behavioral counseling modules (described below).
Upon their return, participants were randomly assigned
to treatment conditions based on a computer-generated
algorithm on a 1:1 allocation ratio using simple
randomization without blocking. The computerized ran-
dom allocation sequence was generated by the study
data manager. Participants were enrolled and informed
of their treatment assignment by the Project Coordin-
ator (AJC). The study was approved by the University of
Iowa Institutional Review Board. Reporting of the trial
conforms to CONSORT 2010 Guidelines.
Interventions
Quitline referral
Participants assigned to the comparison condition were
referred via fax by the Project Coordinator (AJC) to the
tobacco quitline for their state of residence. Quitlines
subsequently contacted participants to initiate treatment.
In order to best approximate standard care, no special
arrangements were made with the quitlines to modify
their treatment protocol.
Tailored tobacco intervention
The core component of the Tailored intervention, which
was consistent across all participants in this condition,
was based on standard cognitive behavioral approaches
involving problem solving and coping skills training. The
intervention was delivered by phone over six sessions
lasting approximately 20–30 min each and consisted of
four phases: 1) preparing to quit; 2) going through the
quitting process; 3) maintaining short-term abstinence;
and 4) relapse prevention [23]. Further details about the
smoking cessation intervention are provided in an add-
itional table [Additional file 1]. Calls were conducted ap-
proximately 1 week apart, although the timing could be
adjusted to accommodate Veterans’ schedules.
As noted above, the baseline survey included items to
screen for conditions that have been associated with a
reduced likelihood of cessation. These included elevated
depressive symptoms, risky alcohol use, and concerns
about weight gain. Elevated depressive symptoms were
determined using the Patient Health Questionnaire
(PHQ-9) [24] based on scores of 5–19; those who
scored > 20 and/or who endorsed suicidal ideation were
referred to their primary care or mental health care pro-
vider, as appropriate, and were excluded from the trial.
Risky alcohol use was identified based on a score of ≥ 4
on the Alcohol Use Disorders Identification Test
(AUDIT-C) [25]. Concerns about post-cessation weight
gain were determined based on a score of >5 on a 10-
point scale ranging from 1 (not at all) to 10 (most ever)
[26]. Participants in the Tailored condition could be eli-
gible for anywhere from zero to three of the
supplemental treatment modules, but participation in
each was voluntary and left up to the individual. Coun-
seling related to each of the supplemental modules was
delivered concurrently with the smoking cessation inter-
vention. Each module is briefly described below, with
further details provided in Additional file 1.
Mood management
The intervention for elevated depressive symptoms was
based on behavioral activation (BA) treatment for de-
pression [27]. BA is a brief, structured approach that fo-
cuses on increasing exposure to rewarding activities that
are consistent with one’s values and life goals. In a prior
study, BA was associated with higher quit rates and
greater reductions in depressive symptomatology relative
to standard cessation treatment [28]. The BA approach
used in the present study was adapted from the work of
Lejuez and colleagues [27].
Alcohol risk reduction
The alcohol intervention followed VA/Department of
Defense Clinical Practice Guidelines [29] for addressing
risky alcohol use along with recommendations from the
National Institute on Alcohol Abuse and Alcoholism.
Participants were encouraged to adopt low risk drinking
patterns (i.e., ≤ 2 drinks/day for men and ≤ 1 drink/day
for women) but were allowed to set their own goals [30].
Participants who demonstrated evidence of alcohol
abuse or dependence, based on a score of > 8 on the
AUDIT-C, or who scored ≥ 4 (for men) or ≥ 3 (for
women) on the AUDIT-C and reported a history of prior
alcohol treatment, were offered referral to the hospital’s
substance abuse treatment program but were allowed to
continue with the study and intervention.
Weight management
The weight management intervention was based on a
self-regulation approach [31] and focused on accepting
and minimizing the weight gain that typically accompan-
ies smoking cessation rather than targeting weight loss.
Small, manageable changes in diet and physical activity
were encouraged [32, 33]. Prior to initiating physical ac-
tivity, participants were screened using the Physical Ac-
tivity Readiness Questionnaire [34].
Interventions were delivered by a Ph.D. level social
worker with expertise in substance abuse and a masters
level counselor. Interventionists underwent training con-
sisting of seven didactic sessions (lasting 1–1.5 h each)
with the principal investigator (MWV). These sessions
included a study overview, the smoking cessation coun-
seling protocol, pharmacotherapy, medication selection,
and each of the supplemental counseling modules. Prior
to interacting with participants, interventionists prac-
ticed treatment with a standardized patient, who
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provided feedback on their delivery. In addition, the PI
and interventionists met weekly to review participants
and discuss treatment strategies using a case manage-
ment approach. A small number of calls (~5 %) were
randomly selected for review by the PI for purposes of
assessing fidelity and providing feedback.
Pharmacotherapy
The approach to pharmacotherapy was the same for
both groups. Medication options were based on the
Clinical Practice Guideline [35] and the VA formulary
and included several forms of NRT (patch, gum,
lozenge), bupropion, and varenicline. Combination ther-
apy was also available as appropriate. An initial review of
participants’ EMRs was conducted by a study nurse to
identify potential contraindications related to the medi-
cations as well as to review prior history of pharmaco-
therapy for smoking cessation. Results were summarized
in an electronic grid which highlighted precautions and
contraindications for each medication, along with other
pertinent health information. The study physician (DAK)
reviewed the grid and the participant’s EMR as needed
and identified medications for which the participant was
eligible.
Considering that limited information is available re-
garding which medication is likely to be most effective
for a given patient, study staff then conducted a shared
decision interview with participants to arrive at their
medication preference. The interviewer engaged the par-
ticipant in a discussion of prior experiences with smok-
ing cessation medications and solicited ratings regarding
the importance of eight separate medication attributes.
This information was used to help the participant
choose a medication. Those who selected varenicline or
bupropion completed a brief screen for hopelessness and
suicidal/homicidal ideation. For participants selecting
bupropion, additional queries were made to assess for
potential contraindications (e.g., history of seizures or
head trauma) to supplement information obtained from
the EMR. Participants’ medication choices were commu-
nicated electronically to the study physician and a stand-
ard 12-week supply of pharmacotherapy was mailed
from the pharmacy. As required by VA policy, partici-
pants receiving varenicline were screened over the
phone for neuropsychiatric side effects every 28 days
while on the drug. Participants were allowed to request
a change in their medication one time due to perceived
lack of efficacy or side effects. Pharmacotherapy was
provided free-of-charge.
Measures
Measurements were obtained at baseline and at 12 weeks
and 6 months after participants’ target quit dates.
Follow-up data were collected through phone interview
by study staff who were blinded to participants’ treat-
ment conditions.
Primary outcome
Cessation was determined based on self-reported 7-day
point prevalent abstinence (PPA). To meet criteria for
abstinence, participants had to report no tobacco or e-
cigarette use during the prior 7 days.
Exploratory outcomes
The frequency of depressive symptoms over the prior
2 weeks was measured using the PHQ-9 [24]. The PHQ-9
has good sensitivity and specificity with regard to identify-
ing those with major depression, and is a reliable and valid
measure of severity of depressive symptoms [24].
Alcohol use over the previous week was assessed using
the 7-day Alcohol Timeline Follow-back Calendar
(TFLC) [36]. The TFLC has been found to possess
adequate test-retest reliability [37] and good validity
when compared to collateral report [38].
Dietary intake was assessed using the Starting the
Conversation (STC) questionnaire, an eight-item dietary
assessment tool designed for clinical practice [39]. The
STC assesses the frequency with which various foods were
consumed over the past few months including fruit, vege-
tables, soda, fast food meals or snacks, and added fats.
Despite its brevity, the STC has demonstrated temporal
stability, adequate construct validity, and sensitivity to
change following dietary intervention [39].
Physical activity level was measured using the Rapid
Assessment of Physical Activity (RAPA) [40]. The RAPA
assesses the level and intensity of physical activity as well
as strength and flexibility training. The RAPA has dem-
onstrated good criterion validity based on correlations
with established activity measures, and discriminates
well between those who do versus do not engage in
regular activity [40].
Quitline counseling
For participants in the Quitline Referral condition, con-
tact by their state quitline, enrollment in counseling, and
the number of calls completed were assessed by self-
report.
Descriptive variables
Additional measures were obtained to characterize the
sample. Sociodemographic variables included age, sex,
race and ethnicity, education, marital status, employment,
and household income. Health-related items included
self-reported height, weight, and self-rated health. Partici-
pants were also asked about their history of tobacco use,
prior quit attempts lasting ≥ 24 h, and the presence of
other smokers in their household. Motivation to quit
smoking and to change drinking patterns was assessed
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using the Contemplation Ladder [41]. Nicotine depend-
ence was measured using the Fagerström Test for Nico-
tine Dependence (FTND) [42].
Sample size
An initial sample size of 50 participants (n = 25 per
group) was determined to be adequate to evaluate the
feasibility of the tailored tobacco intervention approach.
Because enrollment accrued more quickly than antici-
pated, a total of 63 rural smokers were ultimately
enrolled and randomized to treatment conditions.
Data analysis
Baseline group comparisons were conducted using chi-
square tests and independent samples t-tests. Twelve-
week and six-month quit rates were compared using
binary logistic regression. Because of the small sample
size and missing data for some variables, multivariable
regression analysis was not performed. The primary ana-
lysis was based on an intention-to-treat/penalized im-
putation approach in which participants who were lost
to follow-up were assumed to be smoking. Results from
complete case analyses are also presented.
Exploratory analyses examined the impact of the sup-
plemental behavioral interventions on depressive symp-
toms, weight, alcohol use, and dietary intake using
repeated measures analysis of variance (ANOVA). These
analyses were restricted to participants in the Tailored
condition who were eligible for and opted to receive the
associated supplemental module and participants in the
Quitline Referral condition who would have met eligibil-
ity criteria for the supplemental intervention if they had
been randomly assigned to the Tailored condition. Given
the small sample sizes, statistical power to detect group
differences on these outcomes was limited; nevertheless,
results are presented for descriptive purposes.
Due to insufficient variation in RAPA scores, the as-
sumptions of repeated measures ANOVA were not met
for physical activity outcomes. Therefore, these data
were dichotomized for purposes of analysis according to
whether or not participants met recommended levels of
aerobic activity. Chi-square tests were used to compare
the proportion of participants in each group who met
activity recommendations at each time point.
Results
Participants were enrolled in the study between June and
November of 2012. The flow of participants through the
study is presented in Fig. 1. Recruitment letters were
mailed to 847 rural Veterans, of whom 706 were excluded.
The main reasons for exclusion included refusal (n = 263),
inability to contact (n = 60), not being reached prior to the
end of the recruitment period (n = 194), and not meeting
initial eligibility criteria (n = 183). Sixty three participants
were randomized to treatment conditions (Tailored = 31;
Quitline Referral = 32).
Baseline characteristics are presented in Table 1.
Participants smoked an average of 24.7 (19.4) cigarettes/
day and had a mean FTND score of 5.7 (2.2). Readiness
to quit smoking averaged 6.6 (1.2) on a scale of 1 to 10.
Approximately 30 % of participants at least partially
attributed a prior relapse to depressed mood (data not
shown). Alcohol and increased appetite/weight gain were
identified as contributors to prior relapse by 21 and
10 %, respectively. No significant differences in baseline
characteristics were observed between groups.
Data extracted from participants’ EMRs revealed a high
frequency of chronic medical and mental health comorbid-
ities; over 40 % rated their health as “fair” or “poor.”
Thirty-eight percent had a documented history of cardio-
vascular disease, 22 % had chronic obstructive pulmonary
disease, and 10 % had diabetes mellitus. With regard to
mental health conditions, 22 % had a history of PTSD,
25 % had a history of an alcohol use disorder, and 32 %
had a history of major depressive disorder (MDD). Margin-
ally more participants in the Tailored condition had a his-
tory of MDD (42 % vs. 22 %), X2 (1) = 2.92, p = .087. None
of the other comorbidities differed significantly by group.
Screening results for supplemental behavioral
interventions
Fifty-eight percent of participants assigned to the Tai-
lored condition were eligible for the mood manage-
ment intervention. The proportions meeting criteria
for the alcohol risk reduction and weight management
interventions were 40 and 23 %, respectively. Eighty-
nine percent of eligible participants accepted the
mood management intervention, while 33 and 100 %
of those who were eligible accepted the alcohol and
weight interventions, respectively. One additional par-
ticipant who scored four on the weight concerns scale
who was mistakenly offered the weight management
module also accepted and received the intervention.
No participants accepted a referral to the facility’s
substance use treatment program. Overall, 16 partici-
pants (52 %) received one of the three supplemental
treatment modules and six participants (19 %) re-
ceived two. Nine participants (29 %) received only the
smoking cessation intervention.
Receipt of telephone counseling
Fifty-two percent of participants assigned to the Tailored
intervention completed all six treatment calls. The over-
all attendance rate was 66 %, and the mean number of
calls completed was 4.0. Five participants dropped out of
the study prior to receiving any counseling. Sixty-seven
percent of those in the Quitline Referral condition re-
ported receiving a call from their state quitline. Of those
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who were contacted, 70 % enrolled in treatment, with a
mean number of quitline counseling calls completed of
2.9 (SD = 1.4; range = 1 to 5).
Choice of pharmacotherapy
Because the same procedure was followed for determin-
ing medications for both treatment conditions and con-
sidering that no group differences in medication
selection were observed, results are summarized for the
sample as a whole (Table 2). The most frequently chosen
medication was the nicotine patch (48 %) followed by
varenicline (37 %). Overall, 54 % selected some form of
combination therapy. Eight participants (13 %) opted for
monotherapy in the form of a single nicotine replacement
product, while one participant (2 %) chose bupropion
only. Varenicline was only available as monotherapy. Six
participants switched medications during the course of
treatment, including two in the Tailored condition (7 %)
and four in the Quitline Referral condition (13 %). Two
participants in the Tailored condition dropped out of
treatment prior to receiving medication.
Primary outcomes
Follow-up data collection occurred between August,
2012 and May, 2013. Self-reported 7-day PPA based on
penalized imputation and complete case analysis are pre-
sented in Table 3. Twelve-week data were available for
74 % of those in the Tailored intervention group and
Recruitment Letters Sent
(N = 847)
Initially Expressed Interest in Study
(n = 141)
Excluded (n = 706)
263 Refused
254 Unable to reach/not contacted
183 Ineligible
22 Deceased
118 Already quit smoking
42 Non-cigarette tobacco user
1 Mental health exclusion
6 Other reason for non-enrollment      
Consented
(N = 69)
Excluded (n = 72)
48 Did not return enrollment forms
22 Refused
1 Already quit smoking



















Not eligible (n = 6)
4 Elevated PHQ or suicidal ideation
1 Already quit smoking
1 Non-cigarette tobacco user
Fig. 1 Enrollment and retention
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94 % of those assigned to Quitline Referral. Although
quit rates tended to be higher in the Tailored group, no
statistically significant differences in abstinence were ob-
served based on either penalized imputation (OR = 1.90;
95 % CI: 0.65, 5.57) or complete case analysis (OR =
3.00; 95 % CI: 0.95, 9.49).
Six month data were obtained for 74 and 88 % of those
in the Tailored and Quitline Referral groups, respectively.
As with the 12-week results, the odds of cessation based
on either penalized imputation methods (OR = 1.05; 95 %
CI: 0.35, 3.12) or complete case analysis (OR = 1.36; 95 %
CI: 0.43, 4.30) did not differ significantly by group.
Exploratory outcomes
Exploratory outcomes are presented in Additional file 2.
Changes in depressive symptoms did not differ by group
(Group x Time interaction, F [2, 26] = 1.38, p = 0.27).
There was, however, a main effect for Time, F (2, 26) =
44.4, p < .001, with depressive symptoms decreasing from
baseline in both groups. Dietary intake scores decreased
(improved) from baseline for the sub-sample as a whole, F
(2, 12) = 6.6, p = .012. Changes over time did not, however,
differ by group, F (2, 12) = 1.0, p = 0.40. With regard to
body weight, no significant main effects for Group or Time
were noted, nor was the Group x Time interaction
significant.
The proportion of participants in each group who met
recommended levels of aerobic activity is also presented
in Additional file 2. Although participants in both groups
tended to be more active at 12 weeks and 6 months than
at baseline, no significant differences between the Tailored
and Quitline Referral conditions were noted at any time
point.
Treatment satisfaction
The majority of participants in both conditions “extremely/
very much” liked that the intervention was delivered by
phone (Tailored = 91 %; Quitline Referral = 71 %, X2 (1) =
2.53, p = .112). The proportion of participants who indi-
cated that treatment was “extremely useful” or “very use-
ful” was 74 % for the Tailored condition and 46 % for the
Quitline Referral condition, X2 (1) = 2.74, p = .096. Forty-
six percent of those in the Quitline Referral condition rated
the intervention as “very/extremely” difficult, compared
with 25 % of those in the Tailored condition, X2 (1) = 1.36,
p = .244. Finally, 86 % of participants in the Tailored condi-
tion indicated that they liked that the treatment addressed
multiple issues in the same intervention “extremely” or
“very much.”
Discussion
Results from this pilot trial support the feasibility of
a tailored tobacco intervention approach delivered
Table 1 Participant characteristics
Variable Quitline Referral Tailored intervention Total
(n = 32) (n = 31) (N = 63)
Sociodemographics
Age 58.5 (8.8) 55.1 (11.5) 56.8 (10.3)
Range 31–73 32–73 31–73
Female, n (%) 5 (15.6) 3 (9.7) 8 (12.7)
Racial or ethnic minority, n (%) 2 (6.3) 1 (3.2) 3 (4.8)
High school or less education, n (%) 15 (46.9) 16 (51.6) 31 (49.2)
Fair or poor self-rated health, n (%) 15 (46.9) 13 (41.9) 28 (44.4)
Married, n (%) 15 (46.9) 15 (48.4) 30 (47.6)
Employed for wages outside home, n (%) 6 (19.4) 10 (35.7) 16 (27.1)
Annual household income < $25,000, n (%) 19 (59.4) 12 (42.9) 31 (51.7)
Smoking-related variables
Cigarettes smoked per day 27.2 (25.7) 22.3 (10.3) 24.7 (19.4)
Age of smoking initiation 15.8 (2.8) 16.7 (3.4) 16.2 (3.1)
Years as regular smoker 40.9 (9.3) 36.5 (10.9) 38.6 (10.3)
Prior quit attempts lasting≥ 24 h 9.4 (19.6) 6.6 (8.1) 8.0 (15.0)
Other smokers in household, n (%) 13 (40.6) 13 (41.9) 26 (41.3)
Nicotine dependencea 5.7 (2.1) 5.6 (2.3) 5.7 (2.2)
Readiness to quit smokingb 6.5 (1.3) 6.8 (1.1) 6.6 (1.2)
aMeasured using the Fagerström Test for Nicotine Dependence [42]. Possible scores range from 0 to 10
bMeasured on a scale of 1 (No interest in quitting) to 10 (Have quit and will never smoke again) using the Contemplation Ladder [41]
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via telephone. The proactive recruitment strategy
identified a sizeable number of smokers who were
interested in receiving cessation treatment that simul-
taneously addressed health concerns previously associ-
ated with reduced quitting success/relapse, suggesting
that smokers are generally receptive to receiving as-
sistance with other health behaviors in the context of
tobacco treatment. However, while 40 % of Veterans
in the intervention group qualified for the alcohol
risk reduction intervention, only 1/3 of these agreed
to participate in the module. Rural Veteran smokers
with risky alcohol use may be less amendable to alco-
hol reduction strategies than interventions that
address mood or concerns about weight gain.
Table 3 7-day Point prevalence abstinence outcomes by group
Outcome Quitline Referral Tailored intervention OR (95 % CI)a
(n = 32) (n = 31)
12-week follow-up
Penalized imputation 25.0 38.7 1.90 (0.65, 5.57)
Complete case analysisb 26.7 52.2 3.00 (0.95, 9.48)
Six-month follow-up
Penalized imputation 28.1 29.0 1.05 (0.35, 3.12)
Complete case analysisc 32.1 39.1 1.36 (0.43, 4.30)
aUnadjusted
bBased on 53 participants (n = 23 for tailored intervention condition and n = 30 for referral condition)
cBased on 51 participants (n = 23 for tailored intervention condition and n = 28 for referral condition)
Table 2 Choice of pharmacotherapy by group
Medicationa Quitline Referral Tailored interventionb Total
n (%) n (%) n (%)
Any use of productc
Nicotine patch 18 (56.3) 12 (38.7) 30 (47.6)
Nicotine gum 10 (31.3) 7 (22.6) 17 (27.0)
Nicotine lozenge 9 (28.1) 9 (29.0) 18 (28.6)
Bupropion 8 (25.0) 5 (16.1) 13 (20.6)
Varenicline 10 (31.3) 13 (41.9) 23 (36.5)
Monotherapy
Nicotine replacement therapy 6 (18.8) 2 (6.5) 8 (12.7)
Nicotine patch 2 (6.3) 0 (0.0) 2 (3.2)
Nicotine gum 3 (9.4) 0 (0.0) 3 (4.8)
Nicotine lozenge 1 (3.1) 2 (6.5) 3 (4.8)
Bupropion 1 (3.1) 1 (3.2) 2 (3.2)
Varenicline 10 (31.3) 13 (41.9) 23 (36.5)
Combination therapy
Any combination NRT 12 (37.5) 11 (35.5) 23 (36.5)
Nicotine patch + nicotine gum 5 (15.6) 5 (16.1) 10 (15.9)
Nicotine patch + nicotine lozenge 7 (21.9) 6 (19.4) 13 (20.6)
Any bupropion + NRT combination 7 (21.9) 4 (12.9) 11 (17.5)
Nicotine patch + bupropion 4 (12.5) 1 (3.2) 5 (7.9)
Nicotine gum + bupropion 2 (6.3) 2 (6.5) 4 (6.3)
Nicotine lozenge + bupropion 1 (3.1) 1 (3.2) 2 (3.2)
aParticipants were allowed to switch their medication choice one time due to perceived lack of efficacy or side effects. A total of six participants switched
medications, including two participants in the Tailored intervention condition and four in the Quitline Referral condition. For those who switched medications,
both choices are represented in the table
bTwo participants in the tailored intervention condition dropped out of the intervention prior to choosing study medication
cAs monotherapy or in combination with another medication
Vander Weg et al. BMC Public Health  (2016) 16:811 Page 8 of 11
Participants also reported a high level of satisfaction
with the individually-tailored treatment approach.
Tailored tobacco counseling and referral to a state
tobacco quitline were associated with comparable ces-
sation outcomes at 12 weeks and 6 months. Although
the odds of quitting were 90 % higher in the Tailored
condition at 12-weeks, this difference was not statisti-
cally significant and was not maintained at 6 months.
It may be, therefore, that standard tobacco quitline
counseling is as effective as a tailored approach,
although it should be noted that those assigned to
the Quitline Referral condition received more inten-
sive medication management tailored to their history
and preferences that differs from what is typically
provided through US tobacco quitlines. Self-reported
7-day PPA rates in both groups were encouraging
overall and generally comparable to or slightly higher
than reported in prior studies involving quitline coun-
seling (e.g., [10, 43]). These quit rates are particularly
promising given the sample’s high prevalence of med-
ical and mental health comorbidities, heavy smoking,
and socioeconomic disadvantage.
Exploratory analyses revealed no differences in depres-
sive symptoms, weight, or dietary intake by treatment
group. However, these results should be considered pre-
liminary due to the small sample sizes. Conclusions re-
garding the effectiveness of either intervention approach
at managing these issues and improving cessation out-
comes will require further study.
Strengths of the study include the proactive recruit-
ment strategy, focus on an underserved group of
smokers (rural Veterans), patient-centered approach that
included optional supplemental interventions to aid with
smoking cessation and associated concerns, and the
novel strategy for selecting pharmacotherapy using
shared decision making. The broad eligibility criteria,
which allowed the enrollment of patients with medical
or mental health conditions who are typically excluded
from smoking cessation studies, was another strength.
Limitations include the modest sample size, which
precluded definitive comparisons of tobacco use and
other outcomes by group. The reliance on self-reported
measures of tobacco use, body weight, and alcohol in-
take is another limitation. Although self-reported smok-
ing status is generally considered valid in the context of
most observational and many types of intervention stud-
ies [44, 45] there is evidence that medical patients, par-
ticularly those with smoking-related illnesses, are more
likely to misreport abstinence [44–46]. Considering that
quitline users who are lost to follow-up are more likely
to be smokers [47] and that a greater proportion of par-
ticipants in the Tailored relative to Quitline Referral con-
dition did not provide follow-up data, results of the
complete-case analyses may have been biased in favor of
the Tailored group. Data pertaining to treatment re-
ceived from the tobacco quitline for those in the Referral
condition was also based on self-report, and may there-
fore be subject to memory lapse or recall bias. It should
also be noted that exploratory analyses were restricted
to those who were eligible for and accepted the supple-
mental interventions in the Tailored condition (and who
were therefore motivated to address these issues), but in-
cluded all participants in the Quitline Referral group
who met eligibility criteria. Consequently, these analyses
may also have been biased in favor of the Tailored
condition.
In addition, we did not have access to information re-
garding the receipt of counseling for chronic health condi-
tions and mental health concerns among patients in the
Quitline Referral condition. Considering that many to-
bacco quitlines attempt to at least partially tailor interven-
tion content based on certain smoker characteristics or
needs [48, 49], it is quite possible that some participants
assigned to the Quitline Referral condition also received a
form of tailored intervention. Unfortunately, we do not
have data from the state tobacco quitlines about the inter-
vention content provided to participants. Furthermore,
the fact that participants in the Quitline Referral condition
were also asked questions about mood, alcohol use, and
weight concerns may also have prompted them to think
about or otherwise address these issues even if they were
not a formal part of their smoking cessation intervention.
Measurement reactivity could also have prompted
changes on these outcomes in the absence of additional
intervention [50]. Consequently, differences in outcomes
between groups that might otherwise have resulted from a
tailored intervention approach may have been attenuated.
Additionally, although we obtained information re-
garding participants’ choice of pharmacotherapy and the
prescriptions they were given, data pertaining to medica-
tion adherence was not collected. Although telephone is
generally regarded as a valid and cost-effective mode of
data collection [51–53], this approach may have ad-
versely affected data quality, particularly among older
and ill participants, due to increased response burden,
diminished hearing, difficulty concentrating, and im-
paired recall [51, 53]. The fact that only 7 % of those
sent recruitment letters were ultimately consented for
the study also raises questions regarding the viability
and potential reach of this approach. However, this
enrollment rate compares quite favorably to community-
and population-based smoking cessation studies, for
which recruitment averages approximately 2 % [54].
Finally, as this was a study of rural Veterans who were
primarily male and white, non-Hispanic, generalizability
to other smokers is uncertain.
The lack of standardization regarding the receipt of
the supplemental treatment modules and provision of
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pharmacotherapy may also be viewed as a limitation.
Decisions regarding whether to receive treatment for de-
pressive symptoms, alcohol use, and weight concerns
were based on positive screens and self-selection. The
choice of pharmacotherapy was also left up to the par-
ticipant, although it was restricted to medications for
which they were medically eligible as determined by the
study physician. While this approach is admittedly infer-
ior to more traditional clinical trials with regard to maxi-
mizing internal validity, it more accurately reflects the
decisions facing patients and providers in routine prac-
tice, and better takes patients’ preferences into account.
Conclusions
An individually-tailored tobacco cessation intervention
which combined pharmacotherapy, behavioral counseling
for smoking cessation, and supplemental treatments for
related concerns was feasible and well-received by partici-
pants. Self-reported cessation rates were encouraging but
did not differ significantly from referral to a tobacco quit-
line. Further work with larger samples is needed to deter-
mine whether shared decision making for medication
selection and tailored counseling that addresses multiple
risk factors for relapse is associated with better outcomes
than standard smoking cessation treatment. Given the
lack of differences in cessation outcome at 6 months, it
may be that standard quitline counseling is equally effect-
ive and more easily disseminated on a large scale.
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